Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension
Authors:
- Christine JosephCJChristine Joseph
- Eva Maria BerghausenEBEva Maria Berghausen
- Bernhard RauchBernhard Rauch
- Henrik Ten FreyhausHFHenrik Ten Freyhaus
- Leoni Luisa Gnatzy-FeikLGLeoni Luisa Gnatzy-Feik
- Max KrauseMKMax Krause
- Dickson W L WongDWDickson W L Wong
- Peter BoorPBPeter Boor
- Stephan BaldusSBStephan Baldus
- Marius VantlerMVMarius Vantler
- Stephan RosenkranzSRStephan Rosenkranz
- 1 February 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 118 (16) , 3225-3238
Abstract
Pulmonary arterial hypertension (PAH) is a devastating disease with limited therapeutic options. Vascular remodelling of pulmonary arteries, characterized by increased proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs), is a hallmark of PAH. Here, we aimed to systematically characterize coagulation-independent effects of key coagulation proteases thrombin and Factor Xa (FXa) and their designated receptors, protease-activated receptor (PAR)-1 and -2, on PASMCs in vitro and experimental PAH in vivo. In human and murine PASMCs, both thrombin and FXa were identified as potent mitogens, and chemoattractants. FXa mediated its responses via PAR-1 and PAR-2, whereas thrombin signalled through PAR-1. Extracellular-signal regulated kinases 1/2, protein kinase B (AKT), and sphingosine kinase 1 were identified as downstream mediators of PAR-1 and PAR-2. Inhibition of FXa or thrombin blunted cellular responses in vitro, but unexpectedly failed to protect against hypoxia-induced PAH in vivo. However, pharmacological inhibition as well as genetic deficiency of both PAR-1 and PAR-2 significantly reduced vascular muscularization of small pulmonary arteries, diminished right ventricular systolic pressure, and right ventricular hypertrophy upon chronic hypoxia compared to wild-type controls. Our findings indicate a coagulation-independent pathogenic potential of thrombin and FXa for pulmonary vascular remodelling via acting through PAR-1 and PAR-2, respectively. While inhibition of single coagulation proteases was ineffective in preventing experimental PAH, our results propose a crucial role for PAR-1 and PAR-2 in its pathobiology, thus identifying PARs but not their dedicated activators FXa and thrombin as suitable targets for the treatment of PAH.Keywords
Funding Information
- Else Kröner Fresenius-Stiftung (2016-A154)
- Köln Fortune Program of the Medical Faculty of the University of Cologne
- ‘Graduate Program in Pharmacology and Experimental Therapeutics’
- Graduate Program GRK-2407
- German Research Foundation
- German Research Foundation
- Deutsche Forschungsgemeinschaft (322900939, 454024652, 445703531)
- German Research Foundation
- Deutsche Forschungsgemeinschaft (SFB/TRR-259, B06, GRK-2407)
This publication has 50 references indexed in Scilit:
- Thrombin Has Biphasic Effects on the Nitric Oxide-cGMP Pathway in Endothelial Cells and Contributes to Experimental Pulmonary HypertensionPLOS ONE, 2013
- Targeting proteinase-activated receptors: therapeutic potential and challengesNature Reviews Drug Discovery, 2012
- A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferationThrombosis and Haemostasis, 2012
- Mechanisms of disease: pulmonary arterial hypertensionNature Reviews Cardiology, 2011
- Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung diseaseArthritis & Rheumatism, 2011
- Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor RivaroxabanMediators of Inflammation, 2011
- Factor Xa Binding to Phosphatidylserine-Containing Membranes Produces an Inactive Membrane-Bound DimerBiophysical Journal, 2009
- Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Absence of Proteinase-Activated Receptor-1 Signaling Affords Protection from Bleomycin-Induced Lung Inflammation and FibrosisThe American Journal of Pathology, 2005
- Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.Journal of Clinical Investigation, 1997